Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion type Assertion NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_head.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion description "[Taken together, these data strongly implicate an unexplored role of Nrf2 in glioma resistance to Carmustine and raise the possible use of Nrf2 inhibitors as adjunct to Carmustine for the treatment of malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_provenance.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion evidence source_evidence_literature NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_provenance.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion SIO_000772 25851054 NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_provenance.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion wasDerivedFrom befree-2016 NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_provenance.
- NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_assertion wasGeneratedBy ECO_0000203 NP1276431.RANELLG7bT5AbIKUQ-lu-LoIDDPcDPAfIphJwmPNMQ4dw130_provenance.